123 related articles for article (PubMed ID: 12008207)
1. Reporting adverse reactions to medicines.
Ferguson R
Nurs N Z; 1999 Dec-2000 Jan; 5(11):11. PubMed ID: 12008207
[No Abstract] [Full Text] [Related]
2. Adverse drug reactions and reporting.
Witte R
Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
[No Abstract] [Full Text] [Related]
3. Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.
Kunac DL; Harrison-Woolrych M; Tatley MV
N Z Med J; 2008 Oct; 121(1283):76-89. PubMed ID: 18841188
[TBL] [Abstract][Full Text] [Related]
4. Recognizing, reporting, and reducing adverse drug reactions.
Brown SD; Landry FJ
South Med J; 2001 Apr; 94(4):370-3. PubMed ID: 11332899
[TBL] [Abstract][Full Text] [Related]
5. Nurses improve medication safety with medication allergy and adverse drug reports.
Valente S; Murray L; Fisher D
J Nurs Care Qual; 2007; 22(4):322-7. PubMed ID: 17873729
[TBL] [Abstract][Full Text] [Related]
6. Nurse reporting of adverse events caused by medicines.
Hunt JM; Gjoka G
Nurs Times; 2003 Dec 9-15; 99(49):24-5. PubMed ID: 14705341
[TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project.
Bousquet PJ; Demoly P; Romano A; Aberer W; Bircher A; Blanca M; Brockow K; Pichler W; Torres MJ; Terreehorst I; Arnoux B; Atanaskovic-Markovic M; Barbaud A; Bijl A; Bonadonna P; Burney PG; Caimmi S; Canonica GW; Cernadas J; Dahlen B; Daures JP; Fernandez J; Gomes E; Gueant JL; Kowalski ML; Kvedariene V; Mertes PM; Martins P; Nizankowska-Mogilnicka E; Papadopoulos N; Ponvert C; Pirmohamed M; Ring J; Salapatas M; Sanz ML; Szczeklik A; Van Ganse E; De Weck AL; Zuberbier T; Merk HF; Sachs B; Sidoroff A;
Allergy; 2009 Feb; 64(2):194-203. PubMed ID: 19178398
[TBL] [Abstract][Full Text] [Related]
8. [The nurse and public health surveillance].
Chevillotte J; Venchiarutti L
Rev Infirm; 2008 Sep; (143):29-31. PubMed ID: 18788665
[No Abstract] [Full Text] [Related]
9. Active surveillance of serious adverse drug reactions in New Zealand children.
Kunac D; Tatley MV; Grimwood K; Reith DM
Arch Dis Child; 2012 Aug; 97(8):761-2. PubMed ID: 22563042
[No Abstract] [Full Text] [Related]
10. [Approaches to classifying adverse reactions of radiopaque substances].
Napolov IuK; Korobkova IZ; Chekavskaia OV; Gorgadze TT; Kalinichev SA
Vestn Rentgenol Radiol; 2006; (4):53-62. PubMed ID: 17633888
[No Abstract] [Full Text] [Related]
11. [Importance of drug surveillance in psychiatry--the AMSP project].
Zullino D; Baumann P; Grohmann R; Greil W
Rev Med Suisse Romande; 2000 Feb; 120(2):105-9. PubMed ID: 10748695
[No Abstract] [Full Text] [Related]
12. Adverse events temporally associated with immunizing agents.
Duclos P; Pless R; Koch J; Hardy M
Can Fam Physician; 1993 Sep; 39():1907-13. PubMed ID: 8219839
[TBL] [Abstract][Full Text] [Related]
13. [Nurse's role in drug surveillance].
Laquintana D; Di Giulio P
Assist Inferm Ric; 2002; 21(4):198-210. PubMed ID: 12674032
[No Abstract] [Full Text] [Related]
14. The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea.
Park CS; Kim TB; Kim SL; Kim JY; Yang KA; Bae YJ; Cho YS; Moon HB
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):919-25. PubMed ID: 18470952
[TBL] [Abstract][Full Text] [Related]
15. Fatal allergic reactions to antibiotics.
Cameron C; Maling T
N Z Med J; 2008 Nov; 121(1286):132-3. PubMed ID: 19098958
[No Abstract] [Full Text] [Related]
16. [Drug surveillance project based on nursing practice].
Assist Inferm Ric; 2002; 21(4):172-6. PubMed ID: 12674027
[TBL] [Abstract][Full Text] [Related]
17. National Centre for Adverse Reactions Monitoring report for the period 1 July, 1994 to 3 June, 1996.
Pillans P
N Z Med J; 1997 Oct; 110(1053):383-5. PubMed ID: 9364188
[No Abstract] [Full Text] [Related]
18. A case for co-ordinated investigation and reporting of hypersensitivity-type drug reactions in the UK.
Watkins J; Wild G; Bex S; Ward AM
Anaesthesia; 2000 Nov; 55(11):1127-8. PubMed ID: 11203409
[No Abstract] [Full Text] [Related]
19. Monitoring adverse drug reactions: scales, profiles, and checklists.
Jordan S; Knight J; Pointon D
Int Nurs Rev; 2004 Dec; 51(4):208-21. PubMed ID: 15530161
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance.
Doogue M
N Z Med J; 2006 Dec; 119(1246):U2334. PubMed ID: 17151708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
